VJHemOnc is committed to improving our service to you

ICML 2019 | Axi-cel in older patients: data from ZUMA-1 and clinical use

VJHemOnc is committed to improving our service to you

Sattva Neelapu

Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, explains the latest results for the use of axicabtagene ciloleucel in older large B-cell lymphoma patients. Dr Neelapu discusses data from both ZUMA-1 (NCT02348216) and real world data from the US Lymphoma CAR-T Consortium. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter